相似文献
1
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
J Dtsch Dermatol Ges. 2018 Feb;16(2):196-198. doi: 10.1111/ddg.13411. Epub 2018 Feb 1.
2
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272. Epub 2017 Jun 16.
3
Severe bullous pemphigoid associated with pembrolizumab therapy for metastatic melanoma with complete regression.
Clin Exp Dermatol. 2017 Apr;42(3):309-312. doi: 10.1111/ced.13042. Epub 2017 Feb 16.
4
Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
J Dermatol. 2017 Oct;44(10):e240-e241. doi: 10.1111/1346-8138.13940. Epub 2017 Jul 5.
5
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Melanoma Res. 2015 Jun;25(3):265-8. doi: 10.1097/CMR.0000000000000155.
6
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.
J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.
7
Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes.
Eur J Dermatol. 2019 Oct 1;29(5):552-554. doi: 10.1684/ejd.2019.3619.
8
Dupilumab for the treatment of nivolumab-induced bullous pemphigoid: a case report and review of the literature.
Dermatol Online J. 2021 Sep 15;27(9). doi: 10.5070/D327955136.
9
Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.
J Cutan Pathol. 2016 Sep;43(9):787-91. doi: 10.1111/cup.12735. Epub 2016 Jun 1.
10
Severe bullous pemphigoid in a metastatic lung cancer patient treated with pembrolizumab.
J Dermatol. 2019 Jul;46(7):e232-e233. doi: 10.1111/1346-8138.14813. Epub 2019 Feb 13.
引用本文的文献
1
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.
Front Med (Lausanne). 2023 Jul 20;10:1208418. doi: 10.3389/fmed.2023.1208418. eCollection 2023.
2
Unilateral and localized bullous eruption in a 71-year-old woman.
Skin (Milwood). 2023 Jan;7(1):635-637. doi: 10.25251/skin.7.1.15. Epub 2023 Jan 10.
3
Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.
Front Oncol. 2023 Mar 3;13:1095694. doi: 10.3389/fonc.2023.1095694. eCollection 2023.
4
Localized bullous pemphigoid: Four clinical cases and a literature review.
Clin Case Rep. 2020 Feb 11;8(3):516-519. doi: 10.1002/ccr3.2697. eCollection 2020 Mar.
5
Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.
Front Med (Lausanne). 2018 Sep 27;5:268. doi: 10.3389/fmed.2018.00268. eCollection 2018.
6
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.
Front Med (Lausanne). 2018 Aug 20;5:220. doi: 10.3389/fmed.2018.00220. eCollection 2018.
7
The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.
Front Med (Lausanne). 2018 Jul 10;5:201. doi: 10.3389/fmed.2018.00201. eCollection 2018.
本文引用的文献
1
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272. Epub 2017 Jun 16.
2
A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
HLA. 2017 Mar;89(3):127-134. doi: 10.1111/tan.12960. Epub 2017 Jan 19.
3
A case report of bullous pemphigoid associated with a melanoma and review of the literature.
Melanoma Res. 2017 Feb;27(1):65-67. doi: 10.1097/CMR.0000000000000307.
4
Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma.
J Dtsch Dermatol Ges. 2016 Jul;14(7):662-81. doi: 10.1111/ddg.13047.
5
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions.
J Cutan Pathol. 2016 Aug;43(8):688-96. doi: 10.1111/cup.12717. Epub 2016 May 8.
6
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.
Cancer Immunol Res. 2016 May;4(5):383-9. doi: 10.1158/2326-6066.CIR-15-0123. Epub 2016 Feb 29.
7
Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.
Histochem Cell Biol. 2012 Oct;138(4):653-67. doi: 10.1007/s00418-012-0981-9. Epub 2012 Jun 12.
8
Clinical features and practical diagnosis of bullous pemphigoid.
Immunol Allergy Clin North Am. 2012 May;32(2):217-32, v. doi: 10.1016/j.iac.2012.04.002. Epub 2012 Apr 17.
9
Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis.
Acta Derm Venereol. 1997 May;77(3):187-90. doi: 10.2340/0001555577187190.
10
Bullous pemphigoid--a report of 86 cases from Taiwan.
Clin Exp Dermatol. 1996 Jan;21(1):20-2.
Zotero 插件